Published on: 11/10/2026
This news was posted by Oregon Today News
Description

People taking popular weight-loss and diabetes drugs are getting a new safety warning. The Food and Drug Administration is requiring all GLP-1 drugs to carry information about a potential increased risk of a rare eye condition that can cause permanent vision loss, according to the FDA’s Nov. 9 drug safety communication. The medications include Ozempic, Wegovy, Mounjaro and Zepbound.
News Source : https://www.oregonlive.com/nation/2026/11/fda-adds-new-warning-to-popular-weight-loss-drugs-what-patients-should-know.html
Other Related News
11/10/2026
Michigan football isnt exactly lacking in funds
11/10/2026
Neil Bhatnagar is pretty fly for a chai guy
11/10/2026
Dear Doctor Roach Im a 70-year-old male whos active and healthy and I eat a varied diet I ...
11/10/2026
City officials say Portland is too broke to give employees represented by the City of Port...
11/10/2026
